Zydus Life launches ANYRA for advanced eye care, shares react
Anyra is indicated for the treatment of neovascular (wet) Age-related Macular Degeneration (AMD), visual impairment due to macular edema secondary to Retinal Vein Occlusion (Branch…
Latest News
Indian OMCs shares slip as crude rally past $70/b amid geopolitical tensions
BPCL, HPCL, and Indian Oil Corporation Ltd shares fell as Brent crude surged above $70 per barrel amid Middle East tensions, Iran actions, and mixed…
Dipan Mehta on NCC fall, AI stock valuations and why he remains positive on CDMO
Dipan Mehta of Elixir Equities advised caution on Netweb Technologies due to high valuations and suggested waiting for a correction or earnings improvement.
Jindal Saw shares decline 4% after API suspends licence over compliance gaps
Jindal Saw on Wednesday said during the API audit, certain ‘non-conformances’ (NCs) were identified, which prompted the issuance of the suspension letter. The same restricts…
Jio and RIL will invest ₹10 lakh crore in AI
Asia’s richest man Mukesh Ambani revealed the long-term investment plan at the AI Impact Summit in New Delhi.
Industry body requests SEBI to defer RBI’s 100% bank guarantee rule implementation by six months
ANMI asks SEBI to halt RBI’s 100% cash collateral rule for CMIs, warning it could harm market liquidity and foreign investment, citing global precedents.
From Axis Bank to Eternal: Morgan Stanley, Jefferies unveil top stock picks after Q3 earnings
Jefferies has released its own top ideas list, focusing on companies expected to deliver strong earnings growth in FY27 compared with FY26.
NCC shares recover after 10% fall as NHAI debars company, subsidiary for two years
NCC has said the company and its step-down subsidiary OB Infrastructure Ltd. have been debarred from participating in any tender/bids issued by NHAI for two…
Brent crude could hit $75 on US-Iran tensions, says Peter McGuire
Peter McGuire, CEO of Trading.com, expects heightened volatility across commodities, with a flight to safety likely supporting the US dollar, gold and silver. He also…
Coforge shares can rally up to 77%, analyst says after Sabre’s earnings call
CLSA has a ‘high-conviction outperform’ rating on Coforge with a price target of ₹2,426 per share, indicating a 77% potential upside from its previous close.